Bug?
658749-2026 - Spania – Diverse medicamente – 23/S/25/SU/DG/A/AM29 - Suministros de… | Licitații Admin
TED — Licitații europene 33690000 — Diverse medicamente · 658749-2026
Spania – Diverse medicamente – 23/S/25/SU/DG/A/AM29 - Suministros de medicamentos no exclusivos de uso humano tipo I incluidos en el grupo terapéutico J de la clasificación ATC con destino al Servicio Canario de la Salud Anunțul 658749-2026 pentru Spania – Diverse medicamente – 23/S/25/SU/DG/A/AM29 - Suministros de medicamentos no exclusivos de uso humano tipo I incluidos en el grupo terapéutico J de la clasificación ATC con destino al Servicio Canario de la Salud este publicat de Dirección General de Recursos Económicos del Servicio Canario de la Salud și este încadrat la codul CPV 33690000.
SintezăAI Documente1 Concurenți Istoric achiziții Anunț Concurenți Istoric Istoric achiziții Documente
Harvey procesează documentele acestei licitații...
Documente atașate1 fișier DOCU
Document oficial
Anunț oficial TED
Detalii complete TED 143 câmpuri publicate
Rezultate, atribuiri și contracte 15
Award criterion description LOT 1.Oferta económica. . 3.1.Código de barras o código QR o código datamatrix en cada unidad mínima de dispensación.
Award criterion number LOT 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 10 | 1 | 10 | 2 | 6 | 1 | 6 | 4 | 6 | 2 | 2 | 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 10 | 1 | 10 | 2 | 6 | 1 | 6 | 4 | 6 | 2 | 2 | 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 10 | 1 | 10 | 2 | 6 | 1 | 6 | 4 | 6 | 2 | 2 | 50 | 10 | 1 | 10 | 2 | 6 | 1 | 6 | 4 | 6 | 2 | 2 | 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 10 | 1 | 10 | 2 | 6 | 1 | 6 | 4 | 6 | 2 | 2 | 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 10 | 1 | 10 | 2 | 6 | 1 | 6 | 4 | 6 | 2 | 2 | 50 | 10 | 1 | 10 | 2 | 6 | 1 | 6 | 4 | 6 | 2 | 2 | 50 | 10 | 1 | 10 | 2 | 6 | 1 | 6 | 4 | 6 | 2 | 2 | 50 | 10 | 1 | 10 | 2 | 6 | 1 | 6 | 4 | 6 | 2 | 2 | 50 | 10 | 1 | 10 | 2 | 6 | 1 | 6 | 4 | 6 | 2 | 2 | 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 9 | 1 | 3 | 2 | 3 | 1 | 2 | 4 | 1 | 2 | 10 | 2 | 10 | 50 | 10 | 1 | 10 | 2 | 6 | 1 | 6 | 4 | 6 | 2 | 2
Award criterion number weight LOT poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa | poi-exa
Award criterion type LOT quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality | quality
Contract conclusion date 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00 | 2026-09-15+02:00
Contract identifier Sandoz L1 | SANDOZ L2 | SANDOZ L4 | NORMON L6 | PFIZER L7 | NORMON L8 | LAB LORIEN L10 | LORIEN L11 | SUN PHARMA 12 | LAPHYSAN L13 | SUN PHARMA L14 | SUN PHARMA L15 | SUN PHARMA L16 | SUN PHARMA L17 | SUN PHARMA L18 | FRESENIUS L19 | NORMON L21 | ACCORD L22 | NORMON L28 | SUN PHARMA L30 | SUN PHARMA L31 | VIVANTA L33 | GLENMARK L34 | NORMON L35 | TARBIS L37 | NORMON L38 | NORMON L39 | TARBIS L40 | TARBIS L41 | TARBIS L42 | REDDY L43 | MACLEODS L44
Contract nature supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies
Contract nature main LOT supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies | supplies
Contract nature main PROC supplies
Contract tender id TEN-0001 | TEN-0002 | TEN-0003 | TEN-0004 | TEN-0005 | TEN-0006 | TEN-0007 | TEN-0008 | TEN-0009 | TEN-0010 | TEN-0011 | TEN-0012 | TEN-0013 | TEN-0014 | TEN-0015 | TEN-0016 | TEN-0017 | TEN-0018 | TEN-0019 | TEN-0020 | TEN-0021 | TEN-0022 | TEN-0023 | TEN-0024 | TEN-0025 | TEN-0026 | TEN-0027 | TEN-0028 | TEN-0029 | TEN-0030 | TEN-0031 | TEN-0032
Result framework maximum value CUR NOTICE EUR
Result framework maximum value NOTICE 19996388.28
Result LOT identifier LOT-0001 | LOT-0012 | LOT-0034 | LOT-0041 | LOT-0042 | LOT-0043 | LOT-0002 | LOT-0003 | LOT-0004 | LOT-0005 | LOT-0006 | LOT-0007 | LOT-0008 | LOT-0009 | LOT-0010 | LOT-0011 | LOT-0014 | LOT-0015 | LOT-0021 | LOT-0024 | LOT-0025 | LOT-0027 | LOT-0028 | LOT-0029 | LOT-0031 | LOT-0032 | LOT-0033 | LOT-0035 | LOT-0036 | LOT-0037 | LOT-0038 | LOT-0039
Result value CUR LOT EUR
Result value LOT 439714 | 315422.8 | 26965.4 | 190357.2 | 1256640 | 33950.36 | 101925.78 | 59786.1 | 292278.27 | 120489.6 | 392299.6 | 100076.68 | 101256.54 | 158336.64 | 249214.77 | 82830.88 | 13868.8 | 1844040 | 89860.32 | 1805923.68 | 17054.4 | 167827 | 54106.8 | 96624 | 430537.8 | 150594.4 | 253000 | 174709.74 | 341880 | 124335.2 | 898782.68 | 346095.07 Alte informații publicate 27
Competition termination PROC false
Customization id eforms-sdk-1.13
Description PROC 23/S/25/SU/DG/A/AM29 - Suministros de medicamentos no exclusivos de uso humano tipo I incluidos en el grupo terapéutico J de la clasificación ATC, con el fin de cubrir las necesidades asistenciales de los centros dependientes del Servicio Canario de la Salud
Dispatch date 2026-09-23+02:00
Dispatch time 10:38:37+02:00
Internal identifier PROC AMSUM/2025/[telefon eliminat]
NL 32
Official language SPA
Ojs number 185/2026
Autoritate contractantă 13
Authority main activity health
Buyer city Las Palmas de Gran Canaria
Buyer contact point Dirección General de Recursos Económicos del Servicio Canario de la Salud
Buyer country ESP
Buyer country sub ES709
Buyer email [email eliminat]
Buyer identifier 21058580149618 | Q8555011I
Buyer internet address http://www3.gobiernodecanarias.org/sanidad/scs/
Buyer legal type ra
Buyer name Loc de executare 5
Place of performance ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP Câștigători și oferte 12
Tender ranked res false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false
Winner city Madrid | Tres Cantos | Alcobendas | Barcelona | BARCELONA | Alcobendas | Barcelona | BARCELONA | Madrid | Madrid | Barcelona | Barcelona | Barcelona
Winner country ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP
Winner country sub ES300 | ES300 | ES300 | ES511 | ES511 | ES300 | ES511 | ES511 | ES300 | ES300 | ES511 | ES511 | ES511
Winner decision date 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00 | 2026-08-05+02:00
Winner email [email eliminat] | [email eliminat] | [email eliminat] | [email eliminat] | [email eliminat] | [email eliminat] | [email eliminat] | [email eliminat] | [email eliminat] | [email eliminat] | [email eliminat] | [email eliminat] | [email eliminat] Organizații și puncte de contact 34
Organisation city buyer Las Palmas de Gran Canaria
Organisation city tenderer Madrid | Tres Cantos | Alcobendas | Barcelona | BARCELONA | Alcobendas | Barcelona | BARCELONA | Madrid | Madrid | Barcelona | Barcelona | Barcelona
Organisation contact point buyer Dirección General de Recursos Económicos del Servicio Canario de la Salud
Organisation country buyer ESP
Organisation country sub buyer ES709
Organisation country sub tenderer ES300 | ES300 | ES300 | ES511 | ES511 | ES300 | ES511 | ES511 | ES300 | ES300 | ES511 | ES511 | ES511
Organisation country tenderer ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP
Organisation email buyer Acord-cadru și sistem dinamic 8
Dps usage LOT none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none
Framework agreement LOT fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix | fa-mix
Framework approximate value CUR NOTICE EUR
Framework approximate value NOTICE 10730784.51
Framework estimated value 439714 | 315422.8 | 26965.4 | 190357.2 | 1256640 | 33950.36 | 101925.78 | 59786.1 | 292278.27 | 120489.6 | 392299.6 | 100076.68 | 101256.54 | 158336.64 | 249214.77 | 82830.88 | 13868.8 | 1844040 | 89860.32 | 1805923.68 | 17054.4 | 167827 | 54106.8 | 96624 | 430537.8 | 150594.4 | 253000 | 174709.74 | 341880 | 124335.2 | 898782.68 | 346095.07
Framework estimated value CUR EUR
Loturi 9
Clean vehicles directive LOT false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false
Description LOT Lote 1. Amoxicilina 1000 Mg - Clavulanico Acido 200 Mg Vial/Amp Inyectable Intravenosa
Electronic auction LOT false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false
Eu fund LOT no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds | no-eu-funds
Gpa LOT false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false | false
Identifier LOT Procedură și anunț 10
Form type result
Legal basis 32014L0024
Legal basis NOTICE 32014L0024
NOTICE identifier 6f232969-e4e7-4697-b214-26b08147fb4b
NOTICE subtype 29
NOTICE title Spania – Diverse medicamente – 23/S/25/SU/DG/A/AM29 - Suministros de medicamentos no exclusivos de uso humano tipo I incluidos en el grupo terapéutico J de la clasificación ATC con destino al Servicio Canario de la Salud
NOTICE type can-standard
NOTICE version 1
Procedure identifier 545168a0-0c38-4145-bee5-d4d3b3924dd6
Clasificare CPV 5
Classification cpv 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000
Main classification LOT 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000 | 33690000
Main classification PROC 33690000
Main classification type LOT cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv | cpv
Main classification type PROC cpv Valori 4
Estimated value CUR LOT EUR
Estimated value LOT 461978 | 141490.8 | 82764 | 316250 | 120489.6 | 398090 | 122452 | 108655.8 | 181427.4 | 293920 | 108988 | 323615.6 | 19069.6 | 1844040 | 117849.6 | 2460678 | 25080 | 593577.6 | 60720 | 96624 | 615054 | 193424 | 330000 | 27871.8 | 320408 | 440048.4 | 157783.12 | 1294392 | 605524.48 | 193696.8 | 1298528 | 42451.2
Total value 10730784.51
Total value CUR EUR Căi de atac 1
Review deadline description LOT De conformidad con el artículo 44 y ss de la LCSP Date de contact publicate în TED 12 Autentifică-te extinde Lote 15. Ceftazidima 1 Gr Vial Parenteral
Lote 18. Ceftriaxona 2 Gr Vial Intravenosa
Lote 37. Valganciclovir 450 Mg Comprimidos Via Oral
Lote 17. Ceftriaxona 1 Gr Vial Intravenosa
Lote 28. Linezolid 600 Mg Comprimidos Via Oral
Reddy Pharma Iberia SAU
Sandoz Farmaceutica
Lote 11. Caspofungina 70 Mg Vial Intravenosa
Lote 41. Maraviroc 150 Mg Comprimidos Via Oral
Lote 6. Ampicilina 1 Gr Vial Parenteral
23/S/25/SU/DG/A/AM29 - Suministros de medicamentos no exclusivos de uso humano tipo I incluidos en el grupo terapéutico J de la clasificación ATC con destino al Servicio Canario de la Salud
2.1.Mensaje ORDERS (pedido). . 3.2.Nombre comercial en la unidad mínima de dispensación (envase primario).
Lote 19. Ciprofloxacino 200 Mg frasco/bolsa perfusión Intravenosa
Lote 40. Abacavir 600 Mg - Lamivudina 300 Mg Comprimidos Via Oral
Lote 22. Colistimetato Sodio 1 Millones UI Vial Inhalatoria
Lote 7. Anidulafungina 100 Mg Vial Intravenosa
2.4.Mensaje DESADV(albarán electrónico incluyendo códigos únicos agregados o individuales de desbloqueo Sevem). . 3.5.Ausencia de látex y derivados del látex en el material fungible del envase primario y secundario que pudiera entrar contacto con el medicamento.
Lote 38. Vancomicina 1gr Vial Intravenosa
PFIZERSLU
Lote 21. Ciprofloxacino 500 Mg Comprimidos Oral
Lote 43. Raltegravir Potasio 600 Mg Comprimidos Vía Oral
Lote 44. Tenofovir 245 Mg - Emtricitabina 200 Mg Comprimidos Via Oral
2.3.Mensaje DESADV (albarán electrónico). . 3.4.Lote y caducidad del medicamento en la unidad mínima de dispensación (envase primario).
LABORATORIOS NORMON, S.A.
GLENMARK FARMACÉUTICA, S.L.U.
LAPHYSAN, S.A.U.
2.3.Mensaje DESADV (albarán electrónico). . 3.4.Principio activo que contiene cualitativa y cuantitativamente en la unidad mínima de dispensación (envase primario).
1.Oferta económica. . 3.1.Código de barras o código QR o código datamatrix en cada unidad mínima de dispensación.
Lote 1. Amoxicilina 1000 Mg - Clavulanico Acido 200 Mg Vial/Amp Inyectable Intravenosa
FRESENIUS KABI ESPAÑA, S.A.
Lote10. Caspofungina 50 Mg Vial Intravenosa
2.5.Permite diferentes fechas de entrega de un mismo pedido, entregas programadas.
1.Oferta económica. . 3.1.Presentación en monodosis.
ACCORD HEALTHCARE, SLU
Lote 12. Cefazolina 1 Gr Vial Intravenosa
Tribunal Administrativo de Contratación Pública de la Comunidad Autónoma de Canarias
23/S/25/SU/DG/A/AM29 - Suministros de medicamentos no exclusivos de uso humano tipo I incluidos en el grupo terapéutico J de la clasificación ATC, con el fin de cubrir las necesidades asistenciales de los centros dependientes del Servicio Canario de la Salud
Lote 8. Azitromicina 500 Mg Comprimidos Via Oral
VIVANTA GENERICS S.R.O. SUCURSAL EN ESPAÑA
Lote 13. Cefepime 1 Gr Vial Parenteral
Lote 2. Amoxicilina 2000 Mg - Clavulanico Acido 200 Mg Vial/Amp Inyectable Intravenosa
2.6.Permite posiciones /líneas de pedidos gratuitas o bonificadas. . 4.2.Mayor estabilidad físico-química a largo plazo tras dilución a la concentración final.
Lote 39. Vancomicina 500 Mg Vial Intravenosa
Lote 31. Meropenem 500 Mg Vial Intravenosa
Lote 34. Posaconazol 40 Mg/105 Ml Suspension Oral
Lote 35. Tobramicina 100 Mg/2ml Vial Parenteral
2.6.Permite posiciones /líneas de pedidos gratuitas o bonificadas.
Lote 14. Cefepime 2 Gr Vial Parenteral
Lote 33. Posaconazol 100 Mg Comprimidos Via Oral
Lote 4. Amoxicilina 500 Mg - Clavulanico Acido 50 Mg Vial/Amp Inyectable Intravenosa
Lote 42. Maraviroc 300 Mg Comprimidos Via Oral
2.4.Mensaje DESADV(albarán electrónico incluyendo códigos únicos agregados o individuales de desbloqueo Sevem). . 3.5.Principio activo que contiene cualitativa y cuantitativamente en la unidad mínima de dispensación (envase primario).
2.1.Mensaje ORDERS (pedido). . 3.2.Código de barras o código QR o código datamatrix en cada unidad mínima de dispensación.
2.2.Mensaje ORDRSP (respuesta a pedido recibido). . 3.3.Nombre comercial en la unidad mínima de dispensación (envase primario).
2.2.Mensaje ORDRSP (respuesta a pedido recibido). . 3.3.Lote y caducidad del medicamento en la unidad mínima de dispensación (envase primario).
SUN PHARMA LABORATORIOS, SLU
LABORATORIOS LORIEN S.L.U.
Dirección General de Recursos Económicos del Servicio Canario de la Salud
Lote 30. Meropenem 1gr Vial Intravenosa
MACLEODS PHARMA ESPAÑA S.L.U
Lote 16. Ceftazidima 2 Gr Vial Intravenosa
TARBIS FARMA S.L.
De conformidad con el artículo 44 y ss de la LCSP
2.5.Permite diferentes fechas de entrega de un mismo pedido, entregas programadas. . 4.1.Mayor estabilidad físico-química a temperatura ambiente del medicamento sin manipular..
[telefon eliminat]
poi-exa
27.45
https://contrataciondelestado.es/wps/poc?uri=deeplink:perfilContratante&idBp=j3wgpomfU3EQK2TEfXGy%2BA%3D%3D
0
32014L[telefon eliminat]B
320408
6
7
8
9
7.1
[email eliminat]
89860.32
TEN-[telefon eliminat]
TEN-0008
TEN-[telefon eliminat]
TEN-0002
TEN-0001
TEN-0007
[email eliminat]
TEN-0006
TEN-0005
TEN-[telefon eliminat]
PFIZER L7
REF TEN-0004/LOT-0041
TEN-[telefon eliminat]
TEN-0014
TEN-0013
TEN-0012
TEN-0011
TEN-0018
TEN-0017
TEN-0016
TEN-[telefon eliminat]
TEN-[telefon eliminat]
SUN PHARMA 12
REF TEN-0018/LOT-0015
[email eliminat]
1294392
0.08
MACLEODS L44
TPA-0020
TPA-0021
TPA-0022
TPA-0023
TPA-[telefon eliminat]
TPA-0025
TPA-0026
TPA-0027
REF TEN-0029/LOT-0036
TPA-0028
TPA-[telefon eliminat]
REF TEN-0012/LOT-0007
[email eliminat]
Barcelona
no-eu-funds
0.18
60720
TPA-0030
TPA-[telefon eliminat]
TPA-0032
SANDOZ L4
2026-09-15+02:00
SANDOZ L2
3369[telefon eliminat]
REF TEN-0021/LOT-0025
TPA-0008
TPA-[telefon eliminat]
[telefon eliminat]
[email eliminat]
0.28
141490.8
82764
[email eliminat]
TPA-0001
09ca0e17-6e33-4078-bf1f-8302eec6297f-01
TPA-0002
TPA-0003
TPA-[telefon eliminat]
TPA-[telefon eliminat]
TPA-0006
TPA-0007
TPA-[telefon eliminat]
VIVANTA L33
REF TEN-0009/LOT-0004
false
249214.77
1844040
0.39
163.96
1.05
TPA-[telefon eliminat]
TPA-0011
TPA-0012
TPA-0013
TPA-0014
REF TEN-0025/LOT-0031
TPA-0015
TPA-0016
TPA-0017
TPA-0018
1.23
RES-[telefon eliminat]
RES-0022
RES-0021
RES-0024
RES-0023
RES-0026
REF TEN-0014/LOT-0009
RES-0025
B87283438
RES-0028
RES-[telefon eliminat]
RES-0029
0.46
supplies
1256640
1.15
[telefon eliminat]
Las Palmas de Gran Canaria
large
13868.8
[email eliminat]
1.35
RES-0011
RES-0010
RES-0013
RES-0012
0.61
RES-[telefon eliminat]
RES-0014
fa-mix
398090
RES-0017
RES-0016
RES-0019
RES-0018
0.57
Madrid
27871.8
3.3
615054
157783.12
España
sme
0.76
RES-0002
RES-0001
RES-0004
RES-0003
RES-0006
RES-0005
2.08
RES-0008
RES-0007
RES-0009
1.37
ESP
1805923.68
293920
ACCORD L22
health
1.54
1.55
1.52
0.85
0.82
B59356394
1.49
430537.8
2.18
[telefon eliminat]
[telefon eliminat]
REF TEN-0024/LOT-0029
2.8
http://www3.gobiernodecanarias.org/sanidad/scs/
SPA
0.98
1.63
0.95
0.96
REF TEN-0032/LOT-[telefon eliminat]
UBO-0032
1.58
UBO-0030
UBO-0031
EUR
[email eliminat]
[telefon eliminat]
UBO-0029
REF TEN-0001/LOT-0001
UBO-0027
UBO-0028
[email eliminat]
UBO-0025
UBO-0026
UBO-0023
UBO-0024
[email eliminat]
UBO-[telefon eliminat]
UBO-0022
1.69
UBO-0020
no
10730784.51
101925.78
193696.8
[telefon eliminat]
LAB LORIEN L10
REF TEN-0027/LOT-0033
UBO-0018
UBO-0019
UBO-0016
UBO-0017
UBO-[telefon eliminat]
UBO-0015
REF TEN-0007/LOT-0002
UBO-0012
UBO-0013
UBO-0010
UBO-[telefon eliminat]
NORMON L8
RES-0031
UBO-0009
RES-0030
REF TEN-0017/LOT-0014
UBO-[telefon eliminat]
RES-0032
UBO-0008
UBO-0005
[telefon eliminat]
UBO-0006
UBO-0003
UBO-0004
UBO-0001
UBO-[telefon eliminat]
LAPHYSAN L13
0.5
NORMON L6
ES300
0.9
2.71
01
REF TEN-0015/LOT-[telefon eliminat]+02:00
t-sme
2.75
928118908
185/2026
120489.6
A08233801
10
11
12
13
LORIEN L11
14
15
16
17
18
19
ra
quality
GLENMARK L34
can-standard
B28089225
167827
108988
21
22
[email eliminat]
27
28
29
LOT-0038
LOT-0037
LOT-0039
REF TEN-0030/LOT-0037
LOT-0041
ES511
LOT-0043
LOT-0042
W0290085J
30
AMSUM/2025/[telefon eliminat]
BARCELONA
33
34
35
37
38
39
158336.64
35[telefon eliminat]
ORG-0014
ORG-0010
40
ORG-0011
41
ORG-0012
open
42
ORG-[telefon eliminat]
[telefon eliminat]
SUN PHARMA L18
2026-08-05+02:00
SUN PHARMA L17
ORG-0007
SUN PHARMA L16
NORMON L28
ORG-0008
REF TEN-0022/LOT-0027
SUN PHARMA L15
ORG-0009
SUN PHARMA L14
18.99
http://www.gobiernodecanarias.org/hacienda/tacp/
LOT-[telefon eliminat]
NORMON L21
Gran Canaria
LOT-0025
LOT-0024
REF TEN-0011/LOT-0006
LOT-0021
REF TEN-0019/LOT-0021
ORG-0003
ORG-0004
ORG-0005
ORG-0006
50
ORG-0001
ORG-0002
REF TEN-0002/LOT-0012
NORMON L35
REF TEN-0028/LOT-0035
NORMON L38
NORMON L39
LOT-0027
LOT-0029
LOT-0028
LOT-0034
LOT-0033
LOT-0036
REDDY L43
LOT-[telefon eliminat]
REF TEN-0006/LOT-0043
LOT-0032
Canarias
LOT-[telefon eliminat]
SUN PHARMA L31
SUN PHARMA L30
19069.6
17054.4
19.45
LOT-0001
LOT-0003
LOT-0002
REF TEN-0003/LOT-[telefon eliminat]
ES709
ES707
ES708
REF TEN-0031/LOT-0038
LOT-0009
FRESENIUS L19
LOT-0008
LOT-[telefon eliminat]
LOT-0004
LOT-0007
LOT-0006
LOT-0012
A28456820
LOT-0011
LOT-0014
tenders
LOT-0010
ES705
ES706
ES703
ES704
A83938175
CON-0013
TPO-0002
CON-[telefon eliminat]
CON-[telefon eliminat]
CON-0014
none
CON-0011
CON-0010
TPO-0001
REF TEN-0026/LOT-0032
CON-0017
CON-0016
CON-0019
CON-0018
A84702844
Q8555011I
CON-0002
CON-[telefon eliminat]
CON-0004
CON-0003
B63424444
CON-0009
CON-0006
[telefon eliminat]
CON-[telefon eliminat]
[email eliminat]
[telefon eliminat]
CON-0008
[email eliminat]
CON-[telefon eliminat]
TARBIS L40
461978
A08130502
eforms-sdk-1.13
CON-0031
CON-0030
CON-0032
[email eliminat]
TARBIS L41
2460678
TARBIS L42
181427.4
439714
CON-0024
CON-0023
CON-0026
CON-[telefon eliminat]
CON-0020
CON-0022
CON-0021
CON-0028
CON-0027
CON-0029
REF TEN-0016/LOT-0011
TARBIS L37
selec-w
96624
TEN-0025
Alcobendas
TEN-0024
TEN-0023
TEN-0022
TEN-0029
REF TEN-0008/LOT-[telefon eliminat]
TEN-0028
TEN-0027
TEN-0026
REF TEN-0005/LOT-0042
TEN-0021
TEN-[telefon eliminat]a0-0c38-4145-bee5-d4d3b3924dd6
33950.36
2026-09-23+02:00
B63878706
TEN-0032
TEN-0031
TEN-0030
[email eliminat]
[telefon eliminat]
REF TEN-0010/LOT-0005
REF TEN-0013/LOT-0008
REF TEN-0020/LOT-0024
[telefon eliminat]
REF TEN-0023/LOT-0028
Tres Cantos
B65112930
28760
6f232969-e4e7-4697-b214-26b08147fb4b
Sandoz L1
10:38:37+02:00
1
Lote 1. Amoxicilina 1000 Mg - Clavulanico Acido 200 Mg Vial/Amp Inyectable Intravenosa
Lote 1. Amoxicilina 1000 Mg - Clavulanico Acido 200 Mg Vial/Amp Inyectable Intravenosa
33690000 — Diverse medicamente
10
Lote10. Caspofungina 50 Mg Vial Intravenosa
Lote10. Caspofungina 50 Mg Vial Intravenosa
33690000 — Diverse medicamente
11
Lote 11. Caspofungina 70 Mg Vial Intravenosa
Lote 11. Caspofungina 70 Mg Vial Intravenosa
33690000 — Diverse medicamente
12
Lote 12. Cefazolina 1 Gr Vial Intravenosa
Lote 12. Cefazolina 1 Gr Vial Intravenosa
33690000 — Diverse medicamente
13
Lote 13. Cefepime 1 Gr Vial Parenteral
Lote 13. Cefepime 1 Gr Vial Parenteral
33690000 — Diverse medicamente
14
Lote 14. Cefepime 2 Gr Vial Parenteral
Lote 14. Cefepime 2 Gr Vial Parenteral
33690000 — Diverse medicamente
15
Lote 15. Ceftazidima 1 Gr Vial Parenteral
Lote 15. Ceftazidima 1 Gr Vial Parenteral
33690000 — Diverse medicamente
16
Lote 16. Ceftazidima 2 Gr Vial Intravenosa
Lote 16. Ceftazidima 2 Gr Vial Intravenosa
33690000 — Diverse medicamente
17
Lote 17. Ceftriaxona 1 Gr Vial Intravenosa
Lote 17. Ceftriaxona 1 Gr Vial Intravenosa
33690000 — Diverse medicamente
18
Lote 18. Ceftriaxona 2 Gr Vial Intravenosa
Lote 18. Ceftriaxona 2 Gr Vial Intravenosa
33690000 — Diverse medicamente
19
Lote 19. Ciprofloxacino 200 Mg frasco/bolsa perfusión Intravenosa
Lote 19. Ciprofloxacino 200 Mg frasco/bolsa perfusión Intravenosa
33690000 — Diverse medicamente
2
Lote 2. Amoxicilina 2000 Mg - Clavulanico Acido 200 Mg Vial/Amp Inyectable Intravenosa
Lote 2. Amoxicilina 2000 Mg - Clavulanico Acido 200 Mg Vial/Amp Inyectable Intravenosa
33690000 — Diverse medicamente
21
Lote 21. Ciprofloxacino 500 Mg Comprimidos Oral
Lote 21. Ciprofloxacino 500 Mg Comprimidos Oral
33690000 — Diverse medicamente
22
Lote 22. Colistimetato Sodio 1 Millones UI Vial Inhalatoria
Lote 22. Colistimetato Sodio 1 Millones UI Vial Inhalatoria
33690000 — Diverse medicamente
28
Lote 28. Linezolid 600 Mg Comprimidos Via Oral
Lote 28. Linezolid 600 Mg Comprimidos Via Oral
33690000 — Diverse medicamente
30
Lote 30. Meropenem 1gr Vial Intravenosa
Lote 30. Meropenem 1gr Vial Intravenosa
33690000 — Diverse medicamente
31
Lote 31. Meropenem 500 Mg Vial Intravenosa
Lote 31. Meropenem 500 Mg Vial Intravenosa
33690000 — Diverse medicamente
33
Lote 33. Posaconazol 100 Mg Comprimidos Via Oral
Lote 33. Posaconazol 100 Mg Comprimidos Via Oral
33690000 — Diverse medicamente
34
Lote 34. Posaconazol 40 Mg/105 Ml Suspension Oral
Lote 34. Posaconazol 40 Mg/105 Ml Suspension Oral
33690000 — Diverse medicamente
35
Lote 35. Tobramicina 100 Mg/2ml Vial Parenteral
Lote 35. Tobramicina 100 Mg/2ml Vial Parenteral
33690000 — Diverse medicamente
37
Lote 37. Valganciclovir 450 Mg Comprimidos Via Oral
Lote 37. Valganciclovir 450 Mg Comprimidos Via Oral
33690000 — Diverse medicamente
38
Lote 38. Vancomicina 1gr Vial Intravenosa
Lote 38. Vancomicina 1gr Vial Intravenosa
33690000 — Diverse medicamente
39
Lote 39. Vancomicina 500 Mg Vial Intravenosa
Lote 39. Vancomicina 500 Mg Vial Intravenosa
33690000 — Diverse medicamente
4
Lote 4. Amoxicilina 500 Mg - Clavulanico Acido 50 Mg Vial/Amp Inyectable Intravenosa
Lote 4. Amoxicilina 500 Mg - Clavulanico Acido 50 Mg Vial/Amp Inyectable Intravenosa
33690000 — Diverse medicamente
40
Lote 40. Abacavir 600 Mg - Lamivudina 300 Mg Comprimidos Via Oral
Lote 40. Abacavir 600 Mg - Lamivudina 300 Mg Comprimidos Via Oral
33690000 — Diverse medicamente
41
Lote 41. Maraviroc 150 Mg Comprimidos Via Oral
Lote 41. Maraviroc 150 Mg Comprimidos Via Oral
33690000 — Diverse medicamente
42
Lote 42. Maraviroc 300 Mg Comprimidos Via Oral
Lote 42. Maraviroc 300 Mg Comprimidos Via Oral
33690000 — Diverse medicamente
43
Lote 43. Raltegravir Potasio 600 Mg Comprimidos Vía Oral
Lote 43. Raltegravir Potasio 600 Mg Comprimidos Vía Oral
33690000 — Diverse medicamente
44
Lote 44. Tenofovir 245 Mg - Emtricitabina 200 Mg Comprimidos Via Oral
Lote 44. Tenofovir 245 Mg - Emtricitabina 200 Mg Comprimidos Via Oral
33690000 — Diverse medicamente
6
Lote 6. Ampicilina 1 Gr Vial Parenteral
Lote 6. Ampicilina 1 Gr Vial Parenteral
33690000 — Diverse medicamente
7
Lote 7. Anidulafungina 100 Mg Vial Intravenosa
Lote 7. Anidulafungina 100 Mg Vial Intravenosa
33690000 — Diverse medicamente
8
Lote 8. Azitromicina 500 Mg Comprimidos Via Oral
Lote 8. Azitromicina 500 Mg Comprimidos Via Oral
33690000 — Diverse medicamente
Rezultate și atribuiri TED LOT-0001 0,79 EUR
Câștigător: Sandoz Farmaceutica · CUI A08233801
Contract Sandoz L1 15 sept. 2026
LOT-0012 1,54 EUR
Câștigător: Sandoz Farmaceutica · CUI A28456820
Contract SANDOZ L2 15 sept. 2026
LOT-0034 1,19 EUR
Câștigător: Sandoz Farmaceutica · CUI B28089225
Contract SANDOZ L4 15 sept. 2026
LOT-0041 0,57 EUR
Câștigător: LABORATORIOS NORMON, S.A. · CUI B63878706
Contract NORMON L6 15 sept. 2026
LOT-0042 30,00 EUR
Câștigător: PFIZERSLU · CUI B63424444
Contract PFIZER L7 15 sept. 2026
LOT-0043 0,32 EUR
Câștigător: LABORATORIOS NORMON, S.A. · CUI A83938175
Contract NORMON L8 15 sept. 2026
LOT-0002 19,45 EUR
Câștigător: LABORATORIOS LORIEN S.L.U. · CUI A08130502
Contract LAB LORIEN L10 15 sept. 2026
LOT-0003 27,45 EUR
Câștigător: LABORATORIOS LORIEN S.L.U. · CUI B65112930
Contract LORIEN L11 15 sept. 2026
LOT-0004 0,46 EUR
Câștigător: SUN PHARMA LABORATORIOS, SLU · CUI W0290085J
Contract SUN PHARMA 12 15 sept. 2026
LOT-0005 1,63 EUR
Câștigător: LAPHYSAN, S.A.U. · CUI B87283438
Contract LAPHYSAN L13 15 sept. 2026
LOT-0006 2,71 EUR
Câștigător: SUN PHARMA LABORATORIOS, SLU · CUI B59356394
Contract SUN PHARMA L14 15 sept. 2026
LOT-0007 0,90 EUR
Câștigător: SUN PHARMA LABORATORIOS, SLU · CUI A84702844
Contract SUN PHARMA L15 15 sept. 2026
LOT-0008 1,52 EUR
Câștigător: SUN PHARMA LABORATORIOS, SLU · CUI 66628355B
Contract SUN PHARMA L16 15 sept. 2026
LOT-0009 0,48 EUR
Câștigător: SUN PHARMA LABORATORIOS, SLU
Contract SUN PHARMA L17 15 sept. 2026
LOT-0010 0,85 EUR
Câștigător: SUN PHARMA LABORATORIOS, SLU
Contract SUN PHARMA L18 15 sept. 2026
LOT-0011 0,76 EUR
Câștigător: FRESENIUS KABI ESPAÑA, S.A.
Contract FRESENIUS L19 15 sept. 2026
LOT-0014 0,08 EUR
Câștigător: LABORATORIOS NORMON, S.A.
Contract NORMON L21 15 sept. 2026
LOT-0015 3,30 EUR
Câștigător: ACCORD HEALTHCARE, SLU
Contract ACCORD L22 15 sept. 2026
LOT-0021 0,61 EUR
Câștigător: LABORATORIOS NORMON, S.A.
Contract NORMON L28 15 sept. 2026
LOT-0024 1,69 EUR
Câștigător: SUN PHARMA LABORATORIOS, SLU
Contract SUN PHARMA L30 15 sept. 2026
LOT-0025 1,02 EUR
Câștigător: SUN PHARMA LABORATORIOS, SLU
Contract SUN PHARMA L31 15 sept. 2026
LOT-0027 1,19 EUR
Câștigător: VIVANTA GENERICS S.R.O. SUCURSAL EN ESPAÑA
Contract VIVANTA L33 15 sept. 2026
LOT-0028 163,96 EUR
Câștigător: GLENMARK FARMACÉUTICA, S.L.U.
Contract GLENMARK L34 15 sept. 2026
LOT-0029 1,22 EUR
Câștigător: LABORATORIOS NORMON, S.A.
Contract NORMON L35 15 sept. 2026
LOT-0031 1,05 EUR
Câștigător: TARBIS FARMA S.L.
Contract TARBIS L37 15 sept. 2026
LOT-0032 2,18 EUR
Câștigător: LABORATORIOS NORMON, S.A.
Contract NORMON L38 15 sept. 2026
LOT-0033 1,15 EUR
Câștigător: LABORATORIOS NORMON, S.A.
Contract NORMON L39 15 sept. 2026
LOT-0035 0,30 EUR
Câștigător: TARBIS FARMA S.L.
Contract TARBIS L40 15 sept. 2026
LOT-0036 7,00 EUR
Câștigător: TARBIS FARMA S.L.
Contract TARBIS L41 15 sept. 2026
LOT-0037 7,10 EUR
Câștigător: TARBIS FARMA S.L.
Contract TARBIS L42 15 sept. 2026
LOT-0038 2,08 EUR
Câștigător: Reddy Pharma Iberia SAU
Contract REDDY L43 15 sept. 2026
LOT-0039 0,18 EUR
Câștigător: MACLEODS PHARMA ESPAÑA S.L.U
Contract MACLEODS L44 15 sept. 2026
Căutări relevante pentru 658749-2026 Legături interne utile pentru CPV, autoritate și expresiile principale din denumirea procedurii.
13.396.941,8EUR
valoare estimată · fără TVA
24 sept. 2026, 03:00
Publicare anunț
SEAP
Previous NOTICE id PROC
09ca0e17-6e33-4078-bf1f-8302eec6297f-01
Procurement relaunch PROC false
Publication date 2026-09-24+02:00
Publication number 658749-2026
Received submissions type code t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders | t-sme | tenders
Received submissions type val 1 | 3 | 4 | 4 | 3 | 3 | 2 | 2 | 2 | 2 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 6 | 6 | 5 | 5 | 7 | 7 | 3 | 3 | 2 | 2 | 5 | 5 | 3 | 3 | 3 | 3 | 5 | 5 | 3 | 3 | 3 | 3 | 2 | 2 | 4 | 4
Subcontracting no | no | no | no | no | no | no | no | no | no | no | no | no | no | no | no | no | no | no | no | no | no | no | no | no | no | no | no | no | no | no | no
Tender identifier REF TEN-0001/LOT-0001 | REF TEN-0002/LOT-0012 | REF TEN-0003/LOT-0034 | REF TEN-0004/LOT-0041 | REF TEN-0005/LOT-0042 | REF TEN-0006/LOT-0043 | REF TEN-0007/LOT-0002 | REF TEN-0008/LOT-0003 | REF TEN-0009/LOT-0004 | REF TEN-0010/LOT-0005 | REF TEN-0011/LOT-0006 | REF TEN-0012/LOT-0007 | REF TEN-0013/LOT-0008 | REF TEN-0014/LOT-0009 | REF TEN-0015/LOT-0010 | REF TEN-0016/LOT-0011 | REF TEN-0017/LOT-0014 | REF TEN-0018/LOT-0015 | REF TEN-0019/LOT-0021 | REF TEN-0020/LOT-0024 | REF TEN-0021/LOT-0025 | REF TEN-0022/LOT-0027 | REF TEN-0023/LOT-0028 | REF TEN-0024/LOT-0029 | REF TEN-0025/LOT-0031 | REF TEN-0026/LOT-0032 | REF TEN-0027/LOT-0033 | REF TEN-0028/LOT-0035 | REF TEN-0029/LOT-0036 | REF TEN-0030/LOT-0037 | REF TEN-0031/LOT-0038 | REF TEN-0032/LOT-0039
Tender LOT identifier LOT-0001 | LOT-0012 | LOT-0034 | LOT-0041 | LOT-0042 | LOT-0043 | LOT-0002 | LOT-0003 | LOT-0004 | LOT-0005 | LOT-0006 | LOT-0007 | LOT-0008 | LOT-0009 | LOT-0010 | LOT-0011 | LOT-0014 | LOT-0015 | LOT-0021 | LOT-0024 | LOT-0025 | LOT-0027 | LOT-0028 | LOT-0029 | LOT-0031 | LOT-0032 | LOT-0033 | LOT-0035 | LOT-0036 | LOT-0037 | LOT-0038 | LOT-0039
Tender value 0.79 | 1.54 | 1.19 | 0.57 | 30 | 0.32 | 19.45 | 27.45 | 0.46 | 1.63 | 2.71 | 0.9 | 1.52 | 0.48 | 0.85 | 0.76 | 0.08 | 3.3 | 0.61 | 1.69 | 1.02 | 1.19 | 163.96 | 1.22 | 1.05 | 2.18 | 1.15 | 0.3 | 7 | 7.1 | 2.08 | 0.18
Tender value CUR highest EUR
Tender value CUR lowest EUR
Tender value highest 0.82 | 1.58 | 1.23 | 0.57 | 30 | 0.4 | 27 | 38 | 0.5 | 1.63 | 2.75 | 0.95 | 1.55 | 0.54 | 0.98 | 0.96 | 0.08 | 3.3 | 0.61 | 2.29 | 1.37 | 2.8 | 183 | 1.22 | 1.49 | 2.8 | 1.35 | 0.39 | 7 | 7.1 | 2.08 | 0.28
Tender value lowest 0 | 0 | 0 | 0 | 0 | 0 | 18.99 | 25.99 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0
Title PROC 23/S/25/SU/DG/A/AM29 - Suministros de medicamentos no exclusivos de uso humano tipo I incluidos en el grupo terapéutico J de la clasificación ATC con destino al Servicio Canario de la Salud
TVH 0.82 | 1.58 | 1.23 | 0.57 | 30 | 0.4 | 27 | 38 | 0.5 | 1.63 | 2.75 | 0.95 | 1.55 | 0.54 | 0.98 | 0.96 | 0.08 | 3.3 | 0.61 | 2.29 | 1.37 | 2.8 | 183 | 1.22 | 1.49 | 2.8 | 1.35 | 0.39 | 7 | 7.1 | 2.08 | 0.28
TVL 0 | 0 | 0 | 0 | 0 | 0 | 18.99 | 25.99 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0
Dirección General de Recursos Económicos del Servicio Canario de la Salud
Buyer profile https://contrataciondelestado.es/wps/poc?uri=deeplink:perfilContratante&idBp=j3wgpomfU3EQK2TEfXGy%2BA%3D%3D
Place of performance country LOT ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP
Place of performance country PROC ESP | ESP | ESP | ESP | ESP | ESP | ESP
Place of performance subdiv LOT ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709 | ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709
Place of performance subdiv PROC ES703 | ES704 | ES705 | ES706 | ES707 | ES708 | ES709
Winner identifier A08233801 | A28456820 | B28089225 | B63878706 | B63424444 | A83938175 | A08130502 | B65112930 | W0290085J | B87283438 | B59356394 | A84702844 | 66628355B
Winner name Sandoz Farmaceutica
Winner owner nationality ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP | ESP
Winner post code 28033 | 28760 | 28108 | 08029 | 08007 | 28108 | 08005 | 08039 | 28003 | 28045 | 08028 | 08029 | 08039
Winner selection status selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w | selec-w
Winner size large | large | large | sme | sme | sme | large | large | sme | sme | sme | sme | sme
[email eliminat]
Organisation email tenderer [email eliminat] | [email eliminat] | [email eliminat] | [email eliminat] | [email eliminat] | [email eliminat] | [email eliminat] | [email eliminat] | [email eliminat] | [email eliminat] | [email eliminat] | [email eliminat] | [email eliminat]
Organisation identifier buyer 21058580149618 | Q8555011I
Organisation identifier tenderer A08233801 | A28456820 | B28089225 | B63878706 | B63424444 | A83938175 | A08130502 | B65112930 | W0290085J | B87283438 | B59356394 | A84702844 | 66628355B
Organisation internet address buyer http://www3.gobiernodecanarias.org/sanidad/scs/
Organisation name buyer Dirección General de Recursos Económicos del Servicio Canario de la Salud
Organisation name tenderer Sandoz Farmaceutica
Organisation post code buyer 35004
Organisation post code tenderer 28033 | 28760 | 28108 | 08029 | 08007 | 28108 | 08005 | 08039 | 28003 | 28045 | 08028 | 08029 | 08039
Organisation tel buyer 928118908
Organisation tel tenderer [telefon eliminat] | [telefon eliminat] | [telefon eliminat] | [telefon eliminat] | [telefon eliminat] | [telefon eliminat] | [telefon eliminat] | [telefon eliminat] | [telefon eliminat] | [telefon eliminat] | [telefon eliminat] | [telefon eliminat] | [telefon eliminat]
Touchpoint city reviewinfo LOT Las Palmas de Gran Canaria
Touchpoint city revieworg LOT Las Palmas de Gran Canaria
Touchpoint country reviewinfo LOT ESP
Touchpoint country revieworg LOT ESP
Touchpoint country sub reviewinfo LOT ES300
Touchpoint country sub revieworg LOT ES705
Touchpoint email reviewinfo LOT [email eliminat]
Touchpoint email revieworg LOT [email eliminat]
Touchpoint internet address reviewinfo LOT http://www.gobiernodecanarias.org/hacienda/tacp/
Touchpoint internet address revieworg LOT http://www.gobiernodecanarias.org/hacienda/tacp/
Touchpoint name reviewinfo LOT Tribunal Administrativo de Contratación Pública de la Comunidad Autónoma de Canarias
Touchpoint name revieworg LOT Tribunal Administrativo de Contratación Pública de la Comunidad Autónoma de Canarias
Touchpoint post code reviewinfo LOT 35007
Touchpoint post code revieworg LOT 35007
Touchpoint tel reviewinfo LOT [telefon eliminat]
Touchpoint tel revieworg LOT [telefon eliminat]
Framework value CUR NOTICE
EUR
Framework value NOTICE 10730784.51
LOT-0001 | LOT-0002 | LOT-0003 | LOT-0004 | LOT-0005 | LOT-0006 | LOT-0007 | LOT-0008 | LOT-0009 | LOT-0010 | LOT-0011 | LOT-0012 | LOT-0014 | LOT-0015 | LOT-0021 | LOT-0024 | LOT-0025 | LOT-0027 | LOT-0028 | LOT-0029 | LOT-0031 | LOT-0032 | LOT-0033 | LOT-0034 | LOT-0035 | LOT-0036 | LOT-0037 | LOT-0038 | LOT-0039 | LOT-0041 | LOT-0042 | LOT-0043
Internal identifier LOT 1 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 2 | 21 | 22 | 28 | 30 | 31 | 33 | 34 | 35 | 37 | 38 | 39 | 4 | 40 | 41 | 42 | 43 | 44 | 6 | 7 | 8
Strategic procurement LOT none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none
Title LOT Lote 1. Amoxicilina 1000 Mg - Clavulanico Acido 200 Mg Vial/Amp Inyectable Intravenosa
Procedure type
open